Adar Poonawalla of the Serum Institute of India
New Delhi:
A minimum of 100 million doses of Covishield- a vaccine that this morning was said to be 90 per cent effective in protecting against the novel coronavirus – will be available by January and 100s of millions could be ready by the end of February, Adar Poonawalla of the Serum Institute of India told NDTV Monday evening.
Mr Poonawalla, whose company has an agreement with the government to mass-manufacture doses of the Covid vaccine, said around 40 million doses had already been produced and that the centre would buy a large number of these doses for Rs 250 or less.
The vaccine will be sold for between Rs 500 and Rs 600 per dose for the private market, he added, explaining that this was to help distributors make some money.
